Immunocore Holdings Income Statement (2019-2026) | IMCR

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2019 Dec2020 Sep2021 Dec2021 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 8.17M8.89M40.30M48.56M56.37M54.66M59.76M64.85M70.16M70.50M75.40M80.25M84.05M93.88M97.96M103.69M104.48M106.68M
Cost of Revenue (Quarter) 0.31M0.07M0.13M0.22M0.35M0.28M0.20M0.25M1.71M0.45M0.33M0.83M1.04M0.51M2.70M0.43M
Gross Profit (Quarter) 8.17M8.89M39.99M48.48M56.25M54.44M58.66M64.57M69.96M70.26M73.69M79.80M83.72M93.05M96.92M103.18M101.78M106.24M
Operating items
Research & Development (Quarter) 23.16M27.06M25.38M27.46M31.83M36.57M38.16M43.25M45.56M57.46M51.07M52.77M60.85M56.47M69.01M70.57M78.82M61.11M
Selling, General & Administrative (Quarter) 27.64M32.85M25.32M13.75M50.60M32.57M42.40M35.47M41.45M39.29M38.64M35.53M42.32M40.20M42.79M39.78M42.65M37.85M
Operating Expenses (Quarter) 50.80M59.90M50.69M41.21M82.43M69.14M78.40M78.72M87.01M96.75M89.71M88.30M103.17M96.67M111.80M110.35M121.47M98.96M
Operating Income (Quarter) -42.67M-51.00M-20.73M7.27M-26.19M-14.70M-13.76M-14.14M-17.05M-26.49M-16.02M-8.50M-19.45M-3.62M-14.88M-7.17M-19.69M7.28M
EBIT (Quarter) -42.67M-51.00M-20.73M7.27M-26.19M-14.70M-19.74M-14.14M-17.05M-26.49M-16.02M-8.50M-19.45M-3.62M-14.88M-7.17M-19.69M7.28M
Non-operating items
Interest & Investment Income (Quarter) 0.01M0.01M0.15M0.70M2.85M3.13M4.28M5.14M5.44M8.25M6.24M5.96M5.17M4.18M4.27M4.12M3.91M3.42M
Other Non Operating Income (Quarter) -6.01M-5.88M11.25M-12.47M-2.41M4.43M8.96M0.99M5.47M4.69M5.06M4.50M3.85M
Non Operating Income (Quarter) -1.80M-1.81M-1.67M-1.40M-0.88M2.31M
Net income details
EBT (Quarter) -44.47M-52.81M-22.39M5.87M-27.37M-19.16M-16.82M0.73M-25.64M-24.08M-10.13M6.09M-24.82M6.08M-9.69M0.30M-15.79M13.27M
Tax Provisions (Quarter) -2.93M0.29M-2.71M-1.47M2.50M0.30M0.19M-0.17M-5.91M0.40M1.50M-2.64M-1.05M1.10M0.61M0.50M14.27M0.30M
Profit After Tax (Quarter) -41.54M-53.10M-20.31M7.34M-29.56M-19.45M-17.01M-14.04M-18.98M-24.44M-11.62M11.98M-23.77M5.70M-10.30M-3.57M-30.06M12.97M
Income from Continuing Operations (Quarter) -41.54M-53.10M-19.69M7.34M-29.87M-19.46M-17.62M0.91M-19.73M-24.48M-11.63M8.74M-23.77M4.98M-10.30M-0.20M-30.06M12.97M
Consolidated Net Income (Quarter) -41.54M-53.10M-19.69M7.34M-29.87M-19.46M-17.62M0.91M-19.73M-24.48M-11.63M8.74M-23.77M4.98M-10.30M-0.20M-30.06M12.97M
Income towards Parent Company (Quarter) -41.54M-53.10M-19.69M7.34M-29.87M-19.46M-17.62M0.91M-19.73M-24.48M-11.63M8.74M-23.77M4.98M-10.30M-0.20M-30.06M12.97M
Net Income towards Common Stockholders (Quarter) -41.54M-53.10M-19.69M7.34M-29.87M-19.46M-17.62M0.91M-19.73M-24.48M-11.63M8.74M-23.77M4.98M-10.30M-0.20M-30.06M12.97M
Additional items
EPS (Basic) (Quarter) -0.95-1.25-0.450.16-0.65-0.40-0.360.02-0.40-0.49-0.230.17-0.480.10-0.200.00-0.600.26
EPS (Diluted) (Quarter) -0.95-1.25-0.450.14-0.65-0.40-0.360.02-0.40-0.49-0.230.17-0.480.10-0.200.00-0.600.25
Shares Outstanding (Quarter) 22.30M26.52M43.80M42.49M43.94M47.00M45.71M48.18M48.69M49.13M48.89M49.88M50.01M50.02M49.99M50.09M50.29M50.40M50.35M50.75M
Shares Outstanding (Diluted) (Quarter) 22.30M26.52M43.80M42.49M43.94M51.44M45.71M48.18M48.69M54.16M48.89M49.88M50.01M52.81M49.99M51.95M50.29M50.40M50.35M52.93M
Shares Outstanding (Entity) (Quarter) 28.67M41.97M60.38M59.13M55.33M56.46M56.40M48.38M61.24M50.29M49.73M50.01M50.02M50.03M50.06M50.18M50.37M50.47M50.69M50.83M
EBITDA (Quarter) -42.67M-51.00M-20.73M7.27M-26.19M-14.70M-19.74M-14.14M-17.05M-26.49M-16.02M-8.50M-19.45M-3.62M-14.88M-7.17M-19.69M7.28M
Interest Expenses (Quarter) 1.82M1.82M1.76M2.10M3.73M1.25M1.27M1.32M0.79M326.13M4.28M4.29M7.04M5.03M73.68M3.04M3.05M69.27M
Tax Rate (Quarter) 6.59%-0.55%12.10%-24.96%-9.12%-1.57%-1.14%-23.94%23.05%-1.66%-14.81%-43.38%4.23%18.08%-6.25%164.47%-90.33%2.27%